The SAGES scoring model leads to personalized treatment via the combination of TACE, TKIs and ICIs for unresectable hepatocellular carcinoma

Background and aimsTranscatheter chemoembolization (TACE) combined with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) shows promising efficacy in treating unresectable hepatocellular carcinoma (uHCC), but the specific patient population that would benefit most from this r...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hesheng Lin, Xueyao Wang, Jianhong Zhong, Ning Peng, Shaoping Liu, Fanjian Zeng, Wenfeng Li, Ze Su, Junjie Ou, Peisheng Wu, Hongbing Yao, Shuqun Li
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-04-01
Series:	Frontiers in Immunology
Assuntos:	immune checkpoint inhibitor overall survival progression-free survival sages score transarterial chemoembolization tyrosine kinase inhibitor
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1802427/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!